US OptionsDetailed Quotes
AMED241220C80000
- 15.90
- 0.000.00%
15min DelayClose Nov 22 16:00 ET
0.00High0.00Low
15.90Open15.90Pre Close0 Volume183 Open Interest80.00Strike Price0.00Turnover20.03%IV5.80%PremiumDec 20, 2024Expiry Date10.64Intrinsic Value100Multiplier26DDays to Expiry5.26Extrinsic Value100Contract SizeAmericanOptions Type0.9922Delta0.0044Gamma8.32Leverage Ratio-0.0113Theta0.0564Rho8.25Eff Leverage0.0052Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?